Findings from the British HIV Association's national clinical audit of first-line antiretroviral therapy and survey of treatment practice and maternity care, 2002

HIV Medicine

Volumn 5, Issue 6, 2004, Pages 415-420

  Brook, M Gary ^a   Curtis, H ^b   Johnson, M A ^c  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

^b British HIV Association   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antenatal testing; Antiretroviral therapy; Clinical audit; Clinical guidelines

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; EFAVIRENZ; GLUCOSE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LIPID; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TENOFOVIR; VIRUS RNA; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL PRACTICE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH SURVEY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRELAND; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL CARE; MEDICAL ASSESSMENT; MEDICAL AUDIT; MEDICAL RECORD; POSTAL MAIL; PRACTICE GUIDELINE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SELF REPORT; UNITED KINGDOM; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; DIAGNOSTIC TESTS, ROUTINE; DRUG THERAPY, COMBINATION; FEMALE; GREAT BRITAIN; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MEDICAL AUDIT; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; SOCIETIES, MEDICAL; TIME FACTORS; VIRAL LOAD;

EID: 9244231762     PISSN: 14642662     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2004.00246.x     Document Type: Article

References (12)

1. National Institute for Clinical Excellence. Principles for Best Practice in Clinical Audit. Oxford, Radcliffe Medical Press Ltd, 2002.
2. Curtis H, Sabin CA, Johnson MA. Findings from the first national clinical audit of treatment for people with HIV. HIV Med 2003; 4: 11-17.
3. BHIVA Writing Committee on Behalf of the BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2001; 2: 276-313.
4. British HIV Association. Guidelines for the Management of HIV Infection in Pregnant Women and Prevention of Mother-to-Child Transmission. www.bhiva.org/guidelines/2003/pregnancy /index.html_2003.
5. Department of Health. Targets Aimed at Reducing the Number of Children Born with HIV. Report from an Expert Group. London, UK Health Departments, HMSO, 1999.
6. BHIVA Writing Committee on Behalf of the BHIVA Executive Committee. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy. HIV Med 2003; 4 (Suppl. 1): 1-41.
7. Sullivan A, Johnson MA, Brook MG, Curtis H. Audit report of newly diagnosed HIV infection. BHIVA Autumn Conference. London, UK, October 2003.
8. Benhamou Y, Bochet M, DiMartino V et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C co-infected patients. Hepatology 1999; 30: 1054-1058.
9. Colin JF, Cazals-Hatem D, Loriot MA et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 1999; 29: 1306-1310.
10. Fantoni M, Del Borgo C, Autore C. Evaluation and management of metabolic and coagulative disorders in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 2003; 17 (Suppl. 1): S162-S169.
11. Gerard Y, Maulin L, Yazdanpanah Y et al. Symptomatic hyperlactataemia: an emerging complication of antiretroviral therapy. AIDS 2000; 14: 2723-2730.
12. Medical Foundation for AIDS and Sexual Health. Recommended Standards for NHS HIV Services. London, MedFASH 2003, (www.medfash.org.uk/publications/documents/Recommended§ andards∀r_NHS _HIV↘rvices.pdf; accessed 25 October 2004).